iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Burns J W & Co. Inc. NY

Burns J W & Co. Inc. NY lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,519 shares of the financial services provider’s stock after selling 129 shares during the quarter. Burns J W & Co. Inc. NY’s holdings in iShares Biotechnology ETF were worth $2,581,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth $30,000. Ashton Thomas Securities LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter valued at about $36,000. Modus Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $41,000. Finally, Voisard Asset Management Group Inc. purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $59,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB traded up $1.29 during mid-day trading on Monday, reaching $134.02. 1,434,925 shares of the company’s stock traded hands, compared to its average volume of 1,451,048. The company has a fifty day simple moving average of $137.95 and a 200-day simple moving average of $141.99. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.